Condition: Down Syndrome · Sponsor: Hôpital le Vinatier
This study evaluates the efficacy of transcranial direct current stimulation (tDCS) for depression with catatonia in individuals with Down syndrome (DS). 62 patients will be randomized to receive 15 sessions of active or sham tDCS. The primary objective is to measure changes in depressive/catatonic symptoms using the Bush-Francis Catatonia Rating Scale (BFCRS). Secondary objectives include safety, cognitive effects, EEG correlates, and biological markers (cortisol, BDNF, cytokines). The study aims to provide a non-pharmacological therapeutic alternative for this population
This description comes directly from the study's public registry record.
JEROME J BRUNELIN, PhD, HDR) · 00334 37 91 54 95 · jerome.brunelin@ch-le-vinatier.fr
VERONIQUE V VIAL · 0033437915522 · veronique.vial@ch-le-vinatier.fr
Always discuss trial participation with your own doctor first.
| Hopital Vinatier | Lyon, Auvergne-Rhône-Alpes, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06866925